Authorized company
MERCK S.A.
MERCK S.A.
Colombia INVIMA·251 registered devices·Mar 20, 2024 – Aug 01, 2033
251
Total devices
5
Risk classes
2024
Earliest
2033
Latest
Recent registrations
Latest 20 INVIMA device registrations
AUTOINYECTOR REBISMART 3.0 / REBISMART 3.0
REBISMART 3.0 / REBISMART 3.0 AUTOINJECTOR
a140fc53eca4be1e1dc4b7f565e143aa
IIaAug 01, 2033
ULTRA PHYSIOLOGICAL FLUID KIT
ULTRA PHYSIOLOGICAL FLUID KIT
a82cc145f5db0248247c2de564e4c88a
IIDec 16, 2031
LINCOMYCIN HYDROCHLORIDE
LINCOMYCIN HYDROCHLORIDE
792f3feccb0a7c01f4be875d56b65260
IJan 10, 2031
DULBECCO’S PHOSPHATE BUFFERED SALINE
DULBECCO'S PHOSPHATE BUFFERED SALINE
dec2a34e027b205eaf1bde8470c0bbfc
IJan 10, 2031
EARLE’S BALANCED SALTS (EBSS)
EARLE'S BALANCED SALTS (EBSS)
7bf168a68bb28e55edad251b5d55be92
IJan 10, 2031
ANTIBIOTIC ANTIMYCOTIC SOLUTION (100×), STABILIZED
ANTIBIOTIC ANTIMYCOTIC SOLUTION (100×), STABILIZED
253cd9c6db1960e6617487bf3ae61ba3
IJan 10, 2031
DIHYDROSTREPTOMYCIN SESQUISULFATE
DIHYDROSTREPTOMYCIN SESQUISULFATE
dcb940b23b6da8fe4a272599fd5ec1ca
IJan 10, 2031
HUMAN MESENCHYMAL-XF EXPANSION MEDIUM
HUMAN MESENCHYMAL-XF EXPANSION MEDIUM
2474add6c5bff6c694be16d9551f26af
IJan 10, 2031
DIMETHYL SULFOXIDE CELL CULTURE TESTED
DIMETHYL SULFOXIDE CELL CULTURE TESTED
4714cf0d7a951834e3f07c5dd6b35190
IJan 10, 2031
DMEM/NUTRIENT MIXTURE F-12 HAM
DMEM/NUTRIENT MIXTURE F-12 HAM
76faef02782db1492a3fc94b78765218
IJan 10, 2031
DULBECCO’S MODIFIED EAGLE’S MEDIUM-HIGH GLUCOSE
DULBECCO'S MODIFIED EAGLE'S MEDIUM-HIGH GLUCOSE
ace0ca5089235ab8318b25916f408306
IJan 10, 2031
FETAL BOVINE SERUM (FBS)
FETAL BOVINE SERUM (FBS)
ca3d5f461811c4588436fe999493af9a
IJan 10, 2031
G 418 DISULFATE SALT
G 418 DISULFATE SALT
32c5ee0a4af2f1b7047999f2c1d2b6e2
IJan 10, 2031
GENTAMICIN SULFATE SALT
GENTAMICIN SULFATE SALT
40f8a9a693e8794a0fad88f59904ca57
IJan 10, 2031
HANKS’ BALANCED SALT SOLUTION (HBSS)
HANKS' BALANCED SALT SOLUTION (HBSS)
d772210015acb06acd9152fd8726dea4
IJan 10, 2031
BLEOMYCIN SULFATE FROM STREPTOMYCES VERTICILLUS
BLEOMYCIN SULFATE FROM STREPTOMYCES VERTICILLUS
53dd45b83e8326845567be43ad6c344e
IJan 10, 2031
ITS LIQUID MEDIA SUPPLEMENT (100×)
ITS LIQUID MEDIA SUPPLEMENT (100×)
70f5577e917ac9eaca8697429ba72086
IJan 10, 2031
KANAMYCIN MONOSULFATE FROM STREPTOMYCES KANAMYCETICUS CELL CULTURE TESTED
KANAMYCIN MONOSULFATE FROM STREPTOMYCES KANAMYCETICUS CELL CULTURE TESTED
fd0f0d6940c625a7b0f98d485338ed09
IJan 10, 2031
L-GLUTAMINE
L-GLUTAMINE
c16f0db8b118e0172062189f7a5453db
IJan 10, 2031
ERYTHROMYCIN
ERYTHROMYCIN
bda8a4573fbc3d088a660c00c610f8a0
IJan 10, 2031
Risk class distribution
Devices by risk class
I
205
81.7% of total
II
22
8.8% of total
Unspecified
15
6.0% of total
IIa
6
2.4% of total
III
3
1.2% of total
About this profile
Explore comprehensive authorized company profile for MERCK S.A. through Pure Global AI's free Colombia medical device database. This company manufactures 251 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Mar 20, 2024 to Aug 01, 2033.
This page provides detailed insights including recent registrations, risk class distribution (II: 22, I: 205, Unspecified: 15, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.